Fig. 3: Repertoire analyses and functional characterization of predominant gene-derived nAbs.
From: Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
a, The graph shows the IGHV-J rearrangement frequencies between vaccinees who were seronegative and seropositive (top), and the frequency within seronegative (middle) and seropositive (bottom) participants. b–g, The graphs show the neutralization potency (IC100) of predominant gene-derived nAbs from the IGHV1-2;IGHJ6-1 (b), IGHV1-69;IGHJ4-1 (c), IGHV2-5;IGHJ4-1 (d), IGHV3-30;IGHJ6-1 (e), IGHV3-53;IGHJ6-1 (f) and IGHV3-66;IGHJ4-1 (g) families, against the original SARS-CoV-2 virus first detected in Wuhan and the B.1.1.7, B.1.351, B.1.1.248 and B.1.617.2 VoCs.
